01 December 2009
Invetech delivers Organovo’s first commercial 3D BioPrinter for manufacturing human tissue and organs
Invetech delivered the world's first production model 3D bio-printer to Organovo, developers of the proprietary NovoGen bioprinting technology. Organovo will supply the units to research institutions investigating human tissue repair and organ replacement.
Dr. Fred Davis, president of Invetech, said, "Building human organs cell-by-cell was considered science fiction not that long ago. Through this clever combination of technology and science we have helped Organovo develop an instrument that will improve people’s lives, making the regenerative medicine that Organovo provides accessible to people around the world."
Further Press Information
Roger Langsdon, Phone: +613 9211 7782, Fax: +613 9211 7703. E-mail media@invetech.com.au.
More News
-
10 June 2010
PREVI™ Isola Wins Prestigious 2010 Gold Medical Design Excellence Award (MDEA) – developed and manufactured by Invetech
-
20 February 2010
THE ECONOMIST: Printing body parts: Making a bit of me – A machine that prints organs is coming to market.
-
18 February 2010
Victorian Premier congratulates Invetech's manufacturing and world-first product developments.
-
Jan / Feb 2010
IVD Technology: Finding success through the IVD product definition process.
-
January 2010
An Invetech Point of View: Contract Manufacturing – Improving the field reliability of complex instruments.
-
01 December 2009
Invetech delivers Organovo’s first commercial 3D BioPrinter for manufacturing human tissue and organs.
-
28 July 2009
Invetech’s San Diego Facility Supports Partnership with The Coca-Cola Company on “Fountain of the Future”.
-
04 June 2009
Invetech Raises the Quality Bar at San Diego facility with ISO13485:2003 Compliance for the Design and Development of Medical Devices.